These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Farne HA; Cates CJ Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945 [TBL] [Abstract][Full Text] [Related]
5. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis. Ismaila AS; Haeussler K; Czira A; Tongbram V; Malmenäs M; Agarwal J; Nassim M; Živković-Gojović M; Shen Y; Dong X; Duarte M; Compton C; Vogelmeier CF; Halpin DMG Adv Ther; 2022 Nov; 39(11):4961-5010. PubMed ID: 35857184 [TBL] [Abstract][Full Text] [Related]
6. Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Fuso L; Mores N; Valente S; Malerba M; Montuschi P Curr Med Chem; 2013; 20(12):1477-95. PubMed ID: 23409722 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β Requena G; Banks V; Czira A; Wood R; Tritton T; Wild R; Compton C; Duarte M; Ismaila AS Int J Chron Obstruct Pulmon Dis; 2022; 17():1781-1795. PubMed ID: 35983168 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis. Donohue JF; Betts KA; Du EX; Altman P; Goyal P; Keininger DL; Gruenberger JB; Signorovitch JE Int J Chron Obstruct Pulmon Dis; 2017; 12():367-381. PubMed ID: 28176892 [TBL] [Abstract][Full Text] [Related]
13. Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study. Hsieh MJ; Chen NH; Cheng SL; Tao CW; Wei YF; Wu YK; Chan MC; Liu SF; Hsu WH; Yang TM; Lin MS; Liu CL; Kuo PH; Tsai YH Int J Chron Obstruct Pulmon Dis; 2022; 17():967-976. PubMed ID: 35510163 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials. Buhl R; de la Hoz A; Xue W; Singh D; Ferguson GT Adv Ther; 2020 Oct; 37(10):4175-4189. PubMed ID: 32671684 [TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease. van Geffen WH; Tan DJ; Walters JA; Walters EH Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859 [TBL] [Abstract][Full Text] [Related]
17. Switching from long-acting beta-agonist and inhaled corticosteroid to long-acting beta-agonist and long-acting muscarinic antagonist for chronic obstructive pulmonary disease: a case report of inhaled corticosteroid withdrawal. Lam JCM Intern Med J; 2020 Sep; 50 Suppl 3():15-18. PubMed ID: 32985094 [TBL] [Abstract][Full Text] [Related]